Life Insurance with Kidney Stones 2026: Underwriting, Rates and No-Exam Options

Getting life insurance with kidney stones in 2026 is far more achievable than most shoppers expect. Kidney stones — the medical term is nephrolithiasis — affect roughly one in ten American adults at some point, and the carriers that write the most policies have spent years refining their guidelines for a condition that is common, treatable, and usually resolved without lasting kidney damage.

For most applicants with a single stone episode that has fully resolved and normal kidney function on recent labs, the outcome is a standard rate class or better. The harder cases are the ones that involve recurrent episodes, an active stone, ongoing obstruction, or reduced kidney function. This guide walks through how underwriters actually read a stone history, what the 2026 market looks like for rates, and how to use no-exam paths when a full workup is not in your favor.

What has changed heading into 2026 is the data. More carriers now pull electronic health records, pharmacy histories, and lab feeds through services like Milliman IntelliScript and the MIB database before a human ever opens your file. That cuts approval times dramatically, but it also means an undisclosed stone history is far more likely to surface than it was five years ago. The practical takeaway is simple: disclose everything, document it well, and let the carrier’s own data work in your favor instead of against you.

Key Takeaways: Life Insurance with Kidney Stones in 2026

• A single, resolved kidney stone is not an automatic decline. Many applicants are approved at Standard rates or better.
• Frequency matters more than the diagnosis itself. Two or more episodes in the last few years typically pushes you toward a Standard or substandard class.
• Kidney function — creatinine, eGFR, and urinalysis — is the single biggest driver of your final offer.
• Lithotripsy and stone surgery usually help your case once you are healed and stone-free, provided you wait the carrier’s required recovery window.
• No-exam accelerated underwriting can approve smaller and mid-size policies without a blood draw, and simplified issue can work when a fully underwritten carrier postpones you.
• Comparing multiple carriers matters more with a stone history than with a clean profile, because guidelines vary widely between insurers.
• Some carriers will still consider Preferred Plus after five or more stone-free years with normal labs, no recurrence, and no metabolic cause — but only a subset of them.
• Never omit or downplay a stone history on an application. A material misstatement can void a policy during the two-year contestability period and trigger rescission even after the policy is issued.

How Underwriters Review Life Insurance with Kidney Stones in 2026

Underwriters do not treat kidney stones as a disease. They treat them as a marker — a signal that something in your urinary or metabolic system may be producing stones. Your file is evaluated on what that signal means for your long-term mortality risk, not on the fact that you once passed a stone.

When a medical director reviews your application, they are effectively answering five questions:

• How many episodes have you had, and when? A single stone in 2019 reads very differently from four stones in the last three years.
• Is the underlying cause known and managed? Dehydration and diet are benign explanations. Hyperparathyroidism, cystinuria, and chronic infection are not.
• Is there any current obstruction or active stone? A stone currently in the ureter, a stent, or a scheduled procedure usually means a postponement rather than a decline.
• How well are your kidneys functioning? Creatinine, eGFR, and urinalysis results carry the most weight in the entire file.
• Are there related conditions? Hypertension, diabetes, gout, obesity, and chronic kidney disease all compound the picture.

Mechanically, your application moves through a fairly predictable chain. The carrier runs your prescription history, checks MIB and often the Motor Vehicle Report, orders a paramedical exam or uses existing medical records, and then — if anything is unclear — requests an Attending Physician Statement (APS) from your urologist or primary care doctor. An APS is the single most common cause of delay in a stone-related file, and it is also the document that most often rescues a borderline case. When a specialist writes that you have been stone-free for three years, that your metabolic workup was normal, and that you are compliant with prevention, underwriters weight that heavily.

The consumer guide published by the National Association of Insurance Commissioners is a useful primer on how carriers classify risk and what information you are entitled to see during underwriting. If you want a deeper explanation of how risk classes translate into pricing, our term life insurance rates by age breakdown shows how age and health class interact.

Single Stone vs. Recurrent Episodes: Why Frequency Drives Your Rate Class

The most common reason a kidney stone applicant lands in a worse class than expected is recurrence. A one-time stone in your twenties, fully cleared, is often viewed as a resolved event. A pattern of stones every 18 months suggests an ongoing metabolic process that has not been controlled — and that is what insurers price for.

The table below shows the typical patterns underwriters see and the general class outcomes that follow. These are illustrative ranges, not promises; every carrier weighs the full profile differently.

Two details move you up or down within these categories. The first is the trend in your labs: stable kidney function over two or three years is worth more than a single good reading. The second is whether your doctor documented a preventive plan — increased fluid intake, dietary changes, or medication such as a thiazide diuretic, allopurinol, or potassium citrate. Documented management reads as lower risk.

It also helps to understand how substandard classes are expressed. Carriers use Table ratings, usually Table 1 through Table 16, where each table adds roughly 25% to the mortality charge built into your premium. The difference between Standard and Table 2, for example, is often a 40–60% premium increase. That gap is the reason it pays to shop: one carrier may put a recurrent-stone applicant at Table 4 while a competitor with more granular stone guidelines puts the same applicant at Standard.

Lithotripsy, Surgery and Other Treatment History

Treatment history tells the underwriter how invasive your stones have been and how well your urinary tract has recovered. Carriers generally distinguish between shock-wave lithotripsy, ureteroscopy with laser fragmentation, and percutaneous nephrolithotomy (PCNL), because the recovery timelines and complication rates differ.

Most insurers want to see that your last procedure is complete, that no fragments or residual stones remain, and that you have passed a reasonable recovery window. That window is often six to twelve months for lithotripsy and ureteroscopy, and sometimes longer after PCNL. If you currently have a stent in place or a stone is actively obstructing, expect a postponement rather than a decline — carriers usually revisit the file once the situation resolves.

Here is what a typical underwriter will ask about your treatment:

• Which procedures you had, and the exact dates
• Whether all stone material was removed or if fragments remain
• Whether you had a stent, and when it was removed
• Any post-procedure imaging and what it showed
• Whether you take preventive medication and how consistently
• Any emergency room visits, infections, or repeat procedures since

You do not need to be stone-free for life to be approved. You do need a clean, well-documented record — which is exactly why ordering your urology notes and imaging reports before you apply saves weeks later.

There is one nuance worth flagging: a history of PCNL, which involves a small incision through the back to remove a large stone, is viewed more seriously than ureteroscopy because it implies a larger stone burden and a greater chance of renal scarring. If you have had PCNL, expect the carrier to want follow-up imaging and a creatinine reading taken well after the procedure, not during the hospital stay. Applicants with a single small stone treated by shock-wave lithotripsy and no recurrence generally have the smoothest path of anyone in this category.

Kidney Function Tests: The Numbers That Matter Most

If you remember one section of this article, make it this one. A stone history is manageable; reduced kidney function is what changes your options.

Underwriters review a standard panel that typically includes:

• Serum creatinine — a waste product that rises when filtration drops
• eGFR — the estimated glomerular filtration rate, reported as mL/min/1.73m², and the number most carriers use as their primary filter
• BUN — blood urea nitrogen, read alongside creatinine
• Urinalysis — checks for protein, blood, and signs of infection
• Serum calcium and parathyroid hormone — ordered when a metabolic cause is suspected
• 24-hour urine collection — sometimes requested to measure calcium, oxalate, citrate, and uric acid excretion

As a general rule of thumb in the 2026 market, an eGFR at or above 60 mL/min/1.73m² with no protein in the urine keeps you in the mainstream of fully underwritten approval. Lower values are not automatically disqualifying, but they push your file into manual review, where a nephrologist’s notes and stability over time become essential.

One practical note: a creatinine reading taken during an acute stone episode is often temporarily elevated and can look alarming on a lab report. If your only abnormal value came from an emergency visit, ask your doctor to re-test once you have fully recovered. A clean follow-up panel frequently replaces that earlier number in the underwriter’s mind.

Applicants with a single functioning kidney — whether from donation, a congenital condition, or a previous nephrectomy — face a separate set of guidelines. A well-functioning solitary kidney with a normal eGFR is insurable at many carriers, often at Standard rather than Preferred, but the file will almost always require a nephrology note and a recent ultrasound or CT. Mention the solitary kidney up front rather than letting the exam uncover it; volunteering the detail signals credibility and speeds up the decision.

Medical Conditions That Change How Carriers View Your Stone History

Kidney stones rarely arrive alone. Underwriters treat a stone history as one data point inside a larger health picture, and certain coexisting conditions move the file in a different direction than stones on their own ever would. The table below summarizes how the most common combinations are read.

The pattern to notice is that the metabolic and structural causes carry more weight than the stones themselves. A person who forms stones because they drink two cups of water a day and live in a hot climate is in a very different risk bucket from someone with genetically driven cystinuria or an overactive parathyroid gland. If you have never had a metabolic workup, and your stones have recurred, asking your doctor to order one can be worth the effort — the results often give an underwriter something concrete and favorable to work with.

Sample 2026 Monthly Rates for Life Insurance with Kidney Stones

The rates below are illustrative sample monthly ranges for a non-smoking applicant with a single stone episode resolved more than five years ago and normal kidney function. They are shown to give you a realistic sense of the market — your actual quote will vary based on your age, health class, state, coverage amount, and the carrier’s specific guidelines.

Read the ranges as the spread between a Preferred-class carrier and a Standard-class carrier for the same person. If your stone history is more complicated — say two episodes in the last three years — expect to sit at or slightly above the top of each range, and add roughly 25% for every substandard table you are assigned. A Table 2 rating on a $500,000, 20-year policy at age 45, for example, might land closer to $155–$175 per month rather than the Standard figure shown above.

Two structural choices influence the price as much as your health class. Choosing a 20-year term instead of a 30-year term typically cuts the premium by 30–40% at the same face amount. Reducing the face amount from $500,000 to $250,000 roughly halves the cost. If a full $500,000 policy prices out higher than you want to pay, laddering two smaller policies with different term lengths often delivers more coverage per dollar than a single large policy.

No-Exam, Accelerated and Simplified Issue Options

When the fully underwritten path is slow, expensive, or blocked, there are three other doors into coverage. Each has trade-offs in price, face amount, and how quickly benefits become fully payable.

Accelerated underwriting is the sweet spot for most stone applicants. Carriers that offer it typically approve up to $1 million or more without a blood draw, relying instead on prescription databases, electronic health records, and a short phone interview. The catch is that an abnormal lab in your record, a recent procedure, or an unresolved stone often routes the file into full underwriting anyway. When that happens, it is not a denial — it is simply the carrier asking for more information.

Simplified issue is the fallback when a fully underwritten carrier postpones or rates you aggressively. These policies ask a handful

Frequently Asked Questions

Can I qualify for life insurance if I have a history of kidney stones?

Yes, many U.S. life insurance carriers approve applicants with kidney stones, especially if the stones were uncomplicated and kidney function remains normal. Underwriting focuses more on recurrence, current kidney health, and related conditions than on a single old stone.

How do kidney stones affect life insurance rates in 2026?

A single resolved stone with normal labs often has little or no rate impact, while recurrent stones, recent surgeries, infections, or reduced kidney function can lead to higher premiums. Carriers may classify you as standard or table-rated instead of preferred if they see ongoing risk.

What medical information does underwriting review for kidney stones?

Insurers typically review the date of your last stone, number and size of stones, treatments such as lithotripsy, and any hospitalizations. They also look at creatinine, eGFR, urinalysis, imaging results, and conditions like hypertension, diabetes, or gout that raise recurrence risk.

Are no-exam life insurance policies available for people with kidney stones?

Yes, simplified issue and final expense policies often skip the medical exam, but they still ask health questions about kidney stones and kidney disease. A mild history may be approved quickly, while recent or severe kidney problems can lead to a decline or higher rate.

How soon after a kidney stone can I apply for life insurance?

Many carriers prefer that you wait until the stone episode is fully resolved, with no obstruction or infection and stable kidney function. Some may require 6 to 12 months after treatment or a normal follow-up imaging or lab result before offering full coverage.

Can I get preferred life insurance rates with a kidney stone history?

Preferred rates may be possible if you had only one stone, no recurrence for several years, normal kidney function, and no related metabolic or cardiovascular conditions. Recurrent stones or abnormal labs usually push you into standard or table-rated underwriting.

What if I have chronic kidney disease or only one kidney?

A donated or solitary kidney with normal function may still qualify for standard coverage with some carriers. Chronic kidney disease, reduced eGFR, proteinuria, or kidney failure usually requires a specialized impaired-risk policy or may be declined for fully underwritten coverage.

Related Reading

Keep researching before you apply:

• Life Insurance with an Autoimmune Disease 2026: Underwriting, Rates an
• Life Insurance with Kidney Stones 2026: Underwriting, Rates and No-Exa
• Life Insurance Basics 2026: Terms, Coverage Types and How to Choose

Underwriting and medical background information in this guide was checked against authoritative sources, including Kidney Stones. Kidney Stones.